sorry you have to wipe out the entire ANZ IF business and half of the fresh milk business to get down to $6 . My understanding is that the logic should flow like below
Revenue margin grow lowers PE —-> Big money enters the market —> Big Jump in SP & Volume —> Support level formed and shown in the chart
Now if you go back and check the support level at $6 what was the revenue and PE back then?
And now check A2’s current forecast Rev and NPAT with whatever worst case scenario you may assume apply the $6 , how does the PE look like? <20 , do you think that’s possible? With all eyes on A2m and Blackmore is trading at PE 40 BXW 30
Just because big money entered market at $ 6 s back then doesn’t mean they will only start to support at $6 . They will start the support whenever the Ideal PE in their mind is reached and you apply that to arrive at a price that’s your bottom support.
So please guys don’t come up with this sort of support levels just because the chart says so. At least have a read the half year and combine with some calcs realism to provide some estimate . You just cannot compare a 10kg watermelon to an apple .
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-17733
-
- There are more pages in this discussion • 7,498 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.952B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $10.27M | 1.490M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 18844 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.85 | 41602 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 11039 | 6.840 |
1 | 3000 | 6.830 |
4 | 17920 | 6.820 |
4 | 9541 | 6.810 |
2 | 5020 | 6.800 |
Price($) | Vol. | No. |
---|---|---|
6.850 | 41602 | 1 |
6.860 | 548 | 1 |
6.870 | 8050 | 3 |
6.880 | 16820 | 3 |
6.890 | 5115 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online